维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

14篇 您的检索式：作者名="MELOSKY B"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Supportive care treatments for toxicities of anti-egfr and other targeted agents显示文摘	Melosky B	2012	Curr Oncol2012，19，1：	1
	2	Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignancies:Canadian rec- ommendations显示文摘	Melosky B Burkes R Rayson D	2009	Curr Oncol2009，16，1：	1
	3	Review of EGFR TKIs in Metastatic NSCLC,Including Ongoing Trials显示文摘	Melosky B	2014	Front Oncol2014，4，：	1
	4	Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal malignaneies: Canadian re- commendations显示文摘	Melosky B Burkes R Rayson D	2009	Curr Oneol2009，16，1：	1
	5	Treatment algorithms for patients with metastatic non- small cell, non-squamous lung cancer显示文摘	Melosky B	2014	Front Oncol2014，4，：	1
	6	Management of skin rash during egfr-targeted monoclonal antibody treatment for gastrointestinal malignancies: Canadian recommendations 显示文摘	Melosky B Burkes R Rayson D	2009	Curr Oncol2009，16，1：	1
	7	Review of EGFR TKIs in metastatic NSCLC, including ongoing trials 显示文摘	Melosky B	2014	Front Oncol2014，5，4：	1
	8	Supportive care treatments for toxicities of anti- egfr and other targeted agents 显示文摘	Melosky B	2012	Curr Oncol2012，19，1：	1
	9	Management of common toxicities in metastatic NSCLC related to anti-lung cancer therapies with EGFR-TKIS 显示文摘	Hirsh V Melosky B	2014	Front Oncol2014，4，：	1
	10	The BC cancer agency experience with gefitinib in advanced non-small cell lung cancer(NSCLC) 显示文摘	Ho C Murray N Melosky B	2004	Proc Am Soc Clin Oncol2004，22，14：	1
	11	Retrospective practice review of treatment of metastatic non-small cell lung cancer with second line erlotinib 显示文摘	MELOSKY B AGULNIK J ASSI H	2008	Curr Oncol2008，15，6：	1
	12	Cutaneous reactions to anticancer agents targeting the epidermal growth material protected by copright factor receptor:A dermatology-oncology perspective显示文摘	Lacouture M Melosky B	2007	Skin Therapy Letter2007，12，：	1
	13	Management of skin rash during EGFR-targeted monoclonal antibody treatment for gastrointestinal maligancies:Canadian recommendations显示文摘	Melosky B Burkes R Rayson D	2009	Current Oncology2009，16，1：	1
	14	Erlotinib ordocetaxel for second-line treatment of non-small cell lung can-cer: a real-world cost-effectiveness analysis显示文摘	Cromwell I van der Hoek K Melosky B	2011	J Thorac On-col2011，6，12：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费